John Trainer - Apr 4, 2023 Form 4 Insider Report for NexImmune, Inc. (NEXI)

Role
Chief Financial Officer
Signature
/s/ John Rudy, attorney-in-fact
Stock symbol
NEXI
Transactions as of
Apr 4, 2023
Transactions value $
$0
Form type
4
Date filed
4/6/2023, 08:41 PM
Previous filing
Nov 25, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEXI Stock Option (right to buy) Award $0 +89.1K $0.00 89.1K Apr 4, 2023 Common Stock 89.1K $0.41 Direct F1
transaction NEXI Stock Option (right to buy) Disposed to Issuer -78.1K -100% 0 Apr 4, 2023 Common Stock 78.1K $4.22 Direct F2
transaction NEXI Stock Option (right to buy) Award +27.7K 27.7K Apr 4, 2023 Common Stock 27.7K $1.23 Direct F2
transaction NEXI Stock Option (right to buy) Award +50.4K 50.4K Apr 4, 2023 Common Stock 50.4K $0.82 Direct F2
transaction NEXI Stock Option (right to buy) Disposed to Issuer -29K -100% 0 Apr 4, 2023 Common Stock 29K $17.00 Direct F3
transaction NEXI Stock Option (right to buy) Award +18.7K 18.7K Apr 4, 2023 Common Stock 18.7K $1.23 Direct F3
transaction NEXI Stock Option (right to buy) Award +10.3K 10.3K Apr 4, 2023 Common Stock 10.3K $0.82 Direct F3
transaction NEXI Stock Option (right to buy) Disposed to Issuer -103K -100% 0 Apr 4, 2023 Common Stock 103K $5.17 Direct F4
transaction NEXI Stock Option (right to buy) Award +89.2K 89.2K Apr 4, 2023 Common Stock 89.2K $1.23 Direct F4
transaction NEXI Stock Option (right to buy) Award +13.7K 13.7K Apr 4, 2023 Common Stock 13.7K $0.82 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest and become exercisable on April 4, 2024, with the remainder vesting in 36 equal monthly installments thereafter, subject to Mr. Trainer's continued service to the corporation on each vesting date.
F2 The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on April 5, 2022, of which 19,525 shares vested, and the remainder of the options will vest in equal monthly installments such that on April 5, 2026, all shares subject to the option shall be vested, subject to Mr. Trainer's continued service on each vesting date.
F3 The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 11, 2021, of which 28,987 shares vested, and the remainder of the options will vest in equal monthly installments such that on February 11, 2025, all shares subject to the option shall be vested, subject to Mr. Trainer's continued service on each vesting date.
F4 The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 5, 2020, of which 130,401 shares vested, and the remainder of the options will vest in equal monthly installments such that on January 8, 2024, all shares subject to the option shall be vested, subject to Mr. Trainer's continued service on each vesting date. Mr. Trainer has exercised his right to purchase an aggregate of 61,769 shares subject to the original option.